Dr. Hsi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 First Street SW
Hilton Bldg 5-30
Rochester, MN 55905Phone+1 507-284-2901
Education & Training
- University of MichiganFellowship, Hematopathology, 1995 - 1996
- University of MichiganResidency, Pathology-Anatomic and Clinical, 1990 - 1995
- University of Michigan Medical SchoolClass of 1990
Certifications & Licensure
- OH State Medical License 1997 - 2026
- MI State Medical License 1992 - 2025
- MN State Medical License 2023 - 2025
- NC State Medical License 2020 - 2025
- IL State Medical License 1996 - 1999
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 125 citationsCBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemiaHideki Makishima, Anna M. Jankowska, Michael A. McDevitt, Christine L. O'Keefe, Simon Dujardin
Blood. 2011-05-26 - 61 citationsMucosa-associated lymphoid tissue-type lymphomas occurring in post- transplantation patientsEric D. Hsi, Timothy P. Singleton, Lode J. Swinnen, Cherie H. Dunphy, Serhan Alkan
The American Journal of Surgical Pathology. 2000-01-01 - 67 citationsDead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma.Vladimir Kolenko, Robert G. Uzzo, Ronald M. Bukowski, Neil H. Bander, Andrew C. Novick
Cancer Research. 1999-06-15
Journal Articles
- Hematopoietic Neoplasms with 9p24/JAK2 Rearrangement: A Multicenter StudyGuilin Tang, Daniel A Arber, Elizabeth M Margolskee, Heesun J Rogers, Robert P Hasserjian, Eric D Hsi, Sa A Wang, Wayne Tam, Adam Bagg, Olga Weinberg, Jonathan I Lake,..., Nature
- CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma Based on Interim PETDavid J Straus, Heiko Schoder, Bruce D Cheson, John C Grecula, Lale Kostakoglu, Eric D Hsi, Leslie L Popplewell, John P Leonard, Craig H Moskowitz, Brad S Kahl, Jonath..., Blood
Abstracts/Posters
- Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep LearningEric D. Hsi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Hypomethylating Agent 5-Azacytidine Sensitizes Peripheral T-Cell Lymphoma to SLAMF7-Targeting Therapeutic Antibody, ElotuzumabEric D. Hsi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Angioimmunoblastic T-Cell Lymphoma: Molecular Characterization of Clonal T and B-Cells and a Patient Derived Xenograft Model of Coexisting T and B-Cell ProliferationsEric D. Hsi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase I Trial of Carfilzomib + R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of CancerClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Demystifying the Lab: CytogeneticsJuly 1st, 2021
- ASH 2018: Dec 1-4December 1st, 2017
- ASH 2016 – Sunday, December 4December 4th, 2015
Grant Support
- Characterization Of Methods For Preservation Of Phosphoproteins In Fixed TissuesNational Cancer Institute2006–2007
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: